ABCC7 p.Thr1246Asn

ClinVar: c.3737C>T , p.Thr1246Ile ? , not provided
CF databases: c.3737C>T , p.Thr1246Ile (CFTR1) ? , A novel mutation was identified by DGGE and direct sequencing; the nucleotide change C->T at position 3869leads to T1246I in exon 20. This mutation was identified on a CF chromosome of an Irish patient, in collaboration with Dr. Watson. This was also discovered by Malone, Haworth, and Schwarz. The mutation was identified by direct DNA sequencing. It is the substitution of a single base (C to T) at position 3869, which results in the replacement of a threonine residue by an isoleucine residue at codon 1246. The patient's other CF mutation is [delta]F508, but we have yet been unable to show that it is on his other CF chromosome. We note that there are a number of other isoleucine substitutions (two with threonine: at 1059 and at 1220) which have been classified as polymorphins, and for this reason we are uncertain of the status of T1246I. We have seen this sequence change once in approximately 60 non-[delta]F508 CF chromosomes so far analysed.
Predicted by SNAP2: A: D (91%), C: D (95%), D: D (95%), E: D (95%), F: D (95%), G: D (95%), H: D (95%), I: D (95%), K: D (95%), L: D (95%), M: D (95%), N: D (95%), P: D (95%), Q: D (95%), R: D (95%), S: D (95%), V: D (95%), W: D (95%), Y: D (95%),
Predicted by PROVEAN: A: D, C: D, D: D, E: D, F: D, G: D, H: D, I: D, K: D, L: D, M: D, N: D, P: D, Q: D, R: D, S: D, V: D, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Vergani P, Lockless SW, Nairn AC, Gadsby DC
CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains.
Nature. 2005 Feb 24;433(7028):876-80., 2005-02-24 [PMID:15729345]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Vergani P, Basso C, Mense M, Nairn AC, Gadsby DC
Control of the CFTR channel's gates.
Biochem Soc Trans. 2005 Nov;33(Pt 5):1003-7., [PMID:16246032]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Muallem D, Vergani P
Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator.
Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):247-55., 2009-01-27 [PMID:18957373]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Szollosi A, Muallem DR, Csanady L, Vergani P
Mutant cycles at CFTR's non-canonical ATP-binding site support little interface separation during gating.
J Gen Physiol. 2011 Jun;137(6):549-62. doi: 10.1085/jgp.201110608. Epub 2011 May 16., [PMID:21576373]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Jih KY, Sohma Y, Hwang TC
Nonintegral stoichiometry in CFTR gating revealed by a pore-lining mutation.
J Gen Physiol. 2012 Oct;140(4):347-59. Epub 2012 Sep 10., [PMID:22966014]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Moran O
Model of the cAMP activation of chloride transport by CFTR channel and the mechanism of potentiators.
J Theor Biol. 2010 Jan 7;262(1):73-9. Epub 2009 Sep 17., [PMID:19766125]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Sorum B, Czege D, Csanady L
Timing of CFTR Pore Opening and Structure of Its Transition State.
Cell. 2015 Oct 22;163(3):724-33. doi: 10.1016/j.cell.2015.09.052. Epub 2015 Oct 22., [PMID:26496611]

Abstract [show]
Comments [show]
Sentences [show]